BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38326996)

  • 1. Feasibility of whole-exome sequencing in fine-needle aspiration specimens of papillary thyroid microcarcinoma for the identification of novel gene mutations.
    Ma L; Gao L; Hu Y; Li X; Liu C; Ji J; Shi X; Pan A; An Y; Luo N; Xia Y; Jiang Y
    Clin Genet; 2024 May; 105(5):567-572. PubMed ID: 38326996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens].
    Dujardin F; Pagès JC; Collin C; de Calan L; Lecomte P; Guyétant S
    Ann Pathol; 2010 Aug; 30(4):252-62. PubMed ID: 20837233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between Ultrasound-guided Fine-needle Aspiration Combined with BRAF
    Zhang Y; Luo YK; Zhang Y; Zhang MB; Guang Y; Xie F; Jiang B; Tang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):517-523. PubMed ID: 31484615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise Detection of Gene Mutations in Fine-Needle Aspiration Specimens of the Papillary Thyroid Microcarcinoma Using Next-Generation Sequencing.
    Yu FX; Hu MX; Zhao HX; Niu LJ; Rong XY; Li WH; Zhu Q; Ying JM; Lyu N
    Int J Endocrinol; 2019; 2019():4723958. PubMed ID: 30915113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Washout DNA copy number analysis by low-coverage whole genome sequencing for assessment of thyroid FNAs.
    Wu L; Zhou Y; Guan Y; Xiao R; Cai J; Chen W; Zheng M; Sun K; Chen C; Huang G; Zhang X; Zhai L; Qian Z; Shen SR
    Front Endocrinol (Lausanne); 2022; 13():888072. PubMed ID: 36313748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
    Lin KL; Wang OC; Zhang XH; Dai XX; Hu XQ; Qu JM
    Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of high-frequency ultrasound combined with fine needle aspiration cytology and BRAF gene for papillary thyroid microcarcinoma.
    Li C; Zhao X; Zhao J; Zhao J; An L; Wu G
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):187-191. PubMed ID: 38650135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.
    Cui Y; Huang X; Guo J; Zhang N; Liang J; Zhang Y; Liao Y; He D
    Technol Cancer Res Treat; 2021; 20():15330338211057982. PubMed ID: 34806478
    [No Abstract]   [Full Text] [Related]  

  • 11. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
    Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
    Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples.
    Kaya C; Dorsaint P; Mercurio S; Campbell AM; Eng KW; Nikiforova MN; Elemento O; Nikiforov YE; Sboner A
    Thyroid; 2021 Apr; 31(4):589-595. PubMed ID: 32948110
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.
    Lan Z; Yang F; Zhang J; Lan Y; Li H; He R
    Acta Cytol; 2023; 67(6):629-638. PubMed ID: 37708867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.
    Fnais N; Soobiah C; Al-Qahtani K; Hamid JS; Perrier L; Straus SE; Tricco AC
    Hum Pathol; 2015 Oct; 46(10):1443-54. PubMed ID: 26232865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma.
    Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M
    Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of cellularity, genomic DNA yields, and technical platforms for BRAF mutational testing in thyroid fine-needle aspirate samples.
    Dyhdalo K; Macnamara S; Brainard J; Underwood D; Tubbs R; Yang B
    Cancer Cytopathol; 2014 Feb; 122(2):114-22. PubMed ID: 24150898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of BRAF v600e immunocytochemistry on FNA direct smears of papillary thyroid carcinoma.
    Wobker SE; Kim LT; Hackman TG; Dodd LG
    Cancer Cytopathol; 2015 Sep; 123(9):531-9. PubMed ID: 26080065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF p.Val600Glu (V600E) mutation detection in thyroid fine needle aspiration cell block samples: a feasibility study.
    Leslie C; Grieu-Iacopetta F; Richter A; Platten M; Murray J; Frost FA; Amanuel B; Kumarasinghe MP
    Pathology; 2015 Aug; 47(5):432-8. PubMed ID: 26154146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P
    Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.